4
Changes in Ownership
HCW Biologics Inc. Filed Acc 0001209191-22-033517
VP of Development acquired 14,570 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiao Jin-an VP of Development | 2022-05-31 | Option exercise | +12,856 | $0.14 | $1,800 | 43,427 | D: show line 1 in the form |
| Jiao Jin-an VP of Development | 2022-05-31 | Option exercise | +1,714 | $0.21 | $360 | 45,141 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Jiao Jin-an VP of Development | 2022-05-31 | Option exercise · Stock Option (Right to Buy) | −12,856 | 18,001 | D: show line 3 in the form | |||||
| Jiao Jin-an VP of Development | 2022-05-31 | Option exercise · Stock Option (Right to Buy) | −1,714 | 6,857 | D: show line 4 in the form |
Loading xslF345X03/doc4.xml…